Vaxcyte Inc. (PCVX) Social Stream
Vaxcyte Inc (PCVX) Price Targets From Analysts
Use the tables below to see what analysts covering Vaxcyte Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
PCVX's average price target has moved down $0.92 over the prior 41 weeks.
PCVX reports an average of 119.75% for its upside potential over the past 50 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
PCVX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 30 weeks, PCVX's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- PCVX has a greater number of analysts covering the stock than 44.6% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, Vaxcyte Inc's upside potential (average analyst target price relative to current price) is higher than 322.62% of them.
- In terms of how Vaxcyte Inc fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 20.19% of that group.
- PCVX has a greater average analyst price target than 272.42% of Pharmaceutical Products stocks.
Make investment decisions regarding PCVX using the data that counts. Try POWR Ratings for free.